A detailed history of Renasant Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Renasant Bank holds 4,828 shares of BMY stock, worth $278,865. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,828
Holding current value
$278,865
% of portfolio
0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $191,478 - $249,849
4,828 New
4,828 $249,000
Q2 2022

Aug 03, 2022

SELL
$72.62 - $79.98 $160,344 - $176,595
-2,208 Reduced 29.15%
5,366 $413,000
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $249,362 - $299,008
4,056 Added 115.29%
7,574 $553,000
Q4 2021

Feb 11, 2022

BUY
$53.63 - $62.52 $188,670 - $219,945
3,518 New
3,518 $219,000
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $200,153 - $225,114
-3,373 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $194,757 - $220,695
3,373 New
3,373 $210,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Renasant Bank Portfolio

Follow Renasant Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renasant Bank, based on Form 13F filings with the SEC.

News

Stay updated on Renasant Bank with notifications on news.